Steven Cohen Neuro Sense Therapeutics Ltd. Transaction History
Point72 Asset Management, L.P.
- $36.6 Billion
- Q3 2024
Shares
1 transactions
Others Institutions Holding NRSN
# of Institutions
9Shares Held
245KCall Options Held
0Put Options Held
0-
Cantor Fitzgerald, L. P. New York, NY79.5KShares$88,2360.01% of portfolio
-
Xtx Topco LTD London, X046KShares$51,0550.0% of portfolio
-
Meitav Dash Investments LTD40KShares$44,4000.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il34.3KShares$38,0500.0% of portfolio
-
Stratos Wealth Partners, Ltd.20KShares$22,2000.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $13M